Financial Statements

Bayer Group Consolidated Statements of Financial Position

  [Table 24]
  March 31,
2014
March 31,
2015
Dec. 31,
2014
  € million € million € million
Noncurrent assets      
Goodwill 10,575 17,331 16,168
Other intangible assets 10,362 16,367 15,653
Property, plant and equipment 9,961 12,099 11,428
Investments accounted for using the equity method 197 253 223
Other financial assets 1,234 1,214 1,107
Other receivables 450 400 447
Deferred taxes 1,593 4,025 2,981
  34,372 51,689 48,007
Current assets      
Inventories 7,391 8,776 8,478
Trade accounts receivable 9,444 11,466 9,097
Other financial assets 790 848 723
Other receivables 1,390 1,587 1,488
Claims for income tax refunds 439 667 588
Cash and cash equivalents 2,631 1,607 1,853
  22,085 24,951 22,227
       
Total assets 56,457 76,640 70,234
       
Equity      
Capital stock of Bayer AG 2,117 2,117 2,117
Capital reserves of Bayer AG 6,167 6,167 6,167
Other reserves 12,721 13,451 11,822
Equity attributable to Bayer AG stockholders 21,005 21,735 20,106
Equity attributable to non-controlling interest 89 128 112
  21,094 21,863 20,218
       
Noncurrent liabilities      
Provisions for pensions and other post-employment benefits 8,647 13,594 12,236
Other provisions 1,806 2,068 2,016
Financial liabilities 8,102 16,921 18,484
Other liabilities 303 1,055 1,088
Deferred taxes 1,220 876 689
  20,078 34,514 34,513
Current liabilities      
Other provisions 5,432 6,196 4,912
Financial liabilities 4,139 6,512 3,376
Trade accounts payable 4,155 5,211 5,363
Income tax liabilities 136 115 63
Other liabilities 1,423 2,229 1,789
  15,285 20,263 15,503
Total equity and liabilities 56,457 76,640 70,234
Last updated: August 16, 2017  Copyright © Bayer AG
http://www.quarterly-report-2015-q1.bayer.com